METTL3 positively regulates PRI-MIR221/222 maturation in an M6A-dependent manner and subsequently promotes Ang-II-induced cardiac hypertrophy by inhibiting DKK2 activation of Wnt/β-catenin signaling [25]. The gene discussed is MIR221; the disease is cardiac hypertrophy.